Mukka Proteins' Q3 FY 2025-26 Quarterly Results
- 13 Feb 2026
Result Summary
- Mukka Proteins Ltd reported a 162.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 113.1%.
- Its expenses for the quarter were up by 160.2% QoQ and 126.6% YoY.
- The net profit increased 295.6% QoQ and increased 1.7% YoY.
- The earnings per share (EPS) of Mukka Proteins Ltd stood at 0.79 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 658.43 | 250.58 | 308.95 | 162.8% | 113.1% |
Total Expenses | 626.65 | 240.86 | 276.51 | 160.2% | 126.6% |
Profit Before Tax | 31.78 | 9.72 | 32.45 | 227.0% | -2.1% |
Tax | 7.37 | 2.39 | 6.17 | 208.4% | 19.4% |
Profit After Tax | 27.26 | 6.89 | 26.80 | 295.6% | 1.7% |
Earnings Per Share | 0.79 | 0.20 | 0.88 | 295.0% | -10.2% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Mukka Proteins Ltd is primarily engaged in the production and distribution of protein-based products. The company operates within the food production industry, focusing on high-quality protein solutions for various applications, including human consumption and animal feed. As of the latest data available, there are no specific details on major recent developments for Mukka Proteins Ltd. However, the company is known for its commitment to quality and innovation in protein processing. The industry itself is characterized by a strong demand for protein sources, driven by increasing health consciousness and the growing global population.
Revenue
In the third quarter of fiscal year 2026 (Q3FY26), Mukka Proteins Ltd reported a total income of ₹658.43 crores. This marks a significant increase from the previous quarter (Q2FY26), where the total income was ₹250.58 crores, demonstrating a quarter-over-quarter (QoQ) growth of 162.8%. Year-over-year (YoY), the revenue also showed a substantial increase of 113.1% from ₹308.95 crores reported in Q3FY25. These figures highlight a robust growth in revenue, indicating an expansion in the company's operations or market reach during this period.
Profitability
The profitability metrics for Mukka Proteins Ltd in Q3FY26 show a profit before tax (PBT) of ₹31.78 crores, which represents a QoQ growth of 227.0% from ₹9.72 crores in Q2FY26. However, there is a slight YoY decrease of 2.1% from ₹32.45 crores in Q3FY25. The tax expense for Q3FY26 was ₹7.37 crores, up from ₹2.39 crores in Q2FY26 and ₹6.17 crores in Q3FY25, reflecting increases of 208.4% QoQ and 19.4% YoY, respectively. The profit after tax (PAT) for Q3FY26 stood at ₹27.26 crores, exhibiting a substantial QoQ growth of 295.6% from ₹6.89 crores in Q2FY26 and a slight YoY increase of 1.7% from ₹26.80 crores in Q3FY25. Earnings per share (EPS) for the quarter was ₹0.79, compared to ₹0.20 in the previous quarter and ₹0.88 a year ago, showing a QoQ increase of 295.0% and a YoY decrease of 10.2%.
Operating Metrics
The operating expenses for Mukka Proteins Ltd in Q3FY26 were ₹626.65 crores, representing a QoQ increase of 160.2% from ₹240.86 crores in Q2FY26 and a YoY increase of 126.6% from ₹276.51 crores in Q3FY25. These figures suggest a significant rise in operating costs, which may be associated with expansion activities or increased operational scale. The company's ability to manage these costs while still achieving substantial revenue growth is reflected in the improved profitability metrics. The earnings per share, although showing a YoY decline, experienced a strong QoQ increase, aligning with the overall trend of improved financial performance during the quarter under review.